Clinical Trials Browser

Phase 2 × Completed × Pancreatic Ductal Adenocarcinoma × Clear all

NCT02440958 2019-02-18

Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial

Phase 2 Completed

Gastrointestinal

Pancreatic Ductal Adenocarcinoma